Dyne Therapeutics (DYN) Assets Average (2020 - 2026)

Dyne Therapeutics (DYN) has 7 years of Assets Average data on file, last reported at $1.1 billion in Q1 2026.

• On a quarterly basis, Assets Average rose 60.51% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 60.51% increase from a year earlier, with the FY2025 full-year figure at $939.1 million, up 119.33% from the prior year.
• Assets Average for Q1 2026 stood at $1.1 billion, up from $1.0 billion in the prior quarter.
• Over the last five years, Assets Average for DYN reached as high as $1.1 billion in Q1 2026 and fell as low as $185.2 million in Q4 2023.
• Historically, Assets Average has averaged $547.6 million across 5 years, with a median of $406.7 million in 2022.
• Across the five-year window, Assets Average tumbled 38.89% in 2023 and surged 294.27% in 2024, its largest moves.
• Year by year, Assets Average stood at $303.0 million in 2022, then tumbled by 38.89% to $185.2 million in 2023, then jumped by 294.27% to $730.0 million in 2024, then surged by 40.68% to $1.0 billion in 2025, then grew by 10.36% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $1.1 billion in Q1 2026, $1.0 billion in Q4 2025, and $798.0 million in Q3 2025.